Gregor Andelfinger
Overview
Explore the profile of Gregor Andelfinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
2417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jafari A, Bhatt K, Niknezhad S, Ajji A, Griffith M, Andelfinger G, et al.
Carbohydr Polym
. 2025 Jan;
352():123140.
PMID: 39843050
The convenience, versatility, and biocompatibility of photocrosslinkable hydrogel precursors make them promising candidates for developing tissue engineering scaffolds. However, the current library of photosensitive materials is limited. This study reports,...
2.
Harvey A, Caru M, Corcia C, Bertrand E, Gagne V, Dandekar S, et al.
Int J Cancer
. 2024 Sep;
156(2):403-416.
PMID: 39244732
An example of chemotherapy-induced cardiotoxicity in cancer survivors is acquired long QT syndrome (aLQTS), which may cause serious yet preventable life-threatening consequences. Our objective was to identify and characterize childhood...
3.
Treatment of RAF1-Related Obstructive Hypertrophic Cardiomyopathy by MEK Inhibition Using Trametinib
Kiamanesh O, Greenway S, Dicke F, Ballantyne B, Mitrovic S, McGrath K, et al.
JACC Case Rep
. 2024 Jun;
29(13):102379.
PMID: 38827265
RASopathies cause nonsarcomeric hypertrophic cardiomyopathy via dysregulated signaling through RAS and upregulated mitogen-activated protein kinase activity. We provide the first report of the successful treatment of an adult with RAF1-associated...
4.
Poirier N, Paquin V, Leclerc S, Lisi V, Marmolejo C, Affia H, et al.
J Immunother Cancer
. 2024 May;
12(5).
PMID: 38754915
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) remains the standard of care for chemotherapy-refractory leukemia patients, but cure rates are still dismal. To prevent leukemia relapse following HSCT, we aim...
5.
Berillo O, Comeau K, Caillon A, Leclerc S, Shokoples B, Mahmoud A, et al.
J Hypertens
. 2024 May;
42(7):1256-1268.
PMID: 38704218
Objectives: γδ T-lymphocytes play a role in angiotensin II (AngII)-induced hypertension, vascular injury and T-cell infiltration in perivascular adipose tissue (PVAT) in mice. Mesenteric arteries of hypertensive mice and subcutaneous...
6.
Chaput D, Andelfinger G
Can J Cardiol
. 2024 Mar;
40(5):789-799.
PMID: 38432396
The term "RASopathies" designates a group of developmental syndromes that are caused by activating variants of the rat sarcoma virus protein (RAS)/mitogen-activated protein kinase (MAPK) cascade. The most prevalent clinical...
7.
Bertrand E, Caru M, Harvey A, Andelfinger G, Laverdiere C, Krajinovic M, et al.
J Electrocardiol
. 2024 Feb;
83:80-94.
PMID: 38382343
Introduction: Early signs of subclinical cardiac damage must be identified before they turn into clinical manifestations. Tailoring a formula is relevant for precise QTc evaluation in childhood acute lymphoblastic leukemia...
8.
Song A, Sindeaux R, Li Y, Affia H, Agnihotri T, Leclerc S, et al.
Cell Rep
. 2023 Dec;
43(1):113616.
PMID: 38150367
Macrophages populate the embryo early in gestation, but their role in development is not well defined. In particular, specification and function of macrophages in intestinal development remain little explored. To...
9.
Laroussi N, Andelfinger G, Bigras J, Boutin C, Brassard M, Dahdah N, et al.
CJC Pediatr Congenit Heart Dis
. 2023 Nov;
2(1):1-2.
PMID: 37970102
No abstract available.
10.
Pierpont E, Bennett A, Schoyer L, Stronach B, Anschutz A, Borrie S, et al.
Am J Med Genet A
. 2023 Nov;
194(4):e63477.
PMID: 37969032
Germline pathogenic variants in the RAS/mitogen-activated protein kinase (MAPK) signaling pathway are the molecular cause of RASopathies, a group of clinically overlapping genetic syndromes. RASopathies constitute a wide clinical spectrum...